Fighting malaria, the Linux way
Big pharma’s tackling malaria this year, Linux-style. Drug producer GlaxoSmithKline has announced it’s giving designs for an anti-malarial project to the public, in hopes that volunteers will step up and help the company deliver a product to the market faster than it would be able to do alone. Glaxo’s bet is that a collaborative approach ...
Big pharma's tackling malaria this year, Linux-style.
Big pharma’s tackling malaria this year, Linux-style.
Drug producer GlaxoSmithKline has announced it’s giving designs for an anti-malarial project to the public, in hopes that volunteers will step up and help the company deliver a product to the market faster than it would be able to do alone. Glaxo’s bet is that a collaborative approach to drug design will pay off despite the financial risk the firm takes by revealing its formula.
Open-source approaches to health and science aren’t new — witness the Human Genome Project — but it’s an idea that has traditionally been confined to the tech world. If Glaxo’s experiment works, we might see a lot more of this strategy down the road.
More from Foreign Policy
America Is a Heartbeat Away From a War It Could Lose
Global war is neither a theoretical contingency nor the fever dream of hawks and militarists.
The West’s Incoherent Critique of Israel’s Gaza Strategy
The reality of fighting Hamas in Gaza makes this war terrible one way or another.
Biden Owns the Israel-Palestine Conflict Now
In tying Washington to Israel’s war in Gaza, the U.S. president now shares responsibility for the broader conflict’s fate.
Taiwan’s Room to Maneuver Shrinks as Biden and Xi Meet
As the latest crisis in the straits wraps up, Taipei is on the back foot.
Sign up for World Brief
FP’s flagship evening newsletter guiding you through the most important world stories of the day, written by Alexandra Sharp. Delivered weekdays.
By submitting your email, you agree to the Privacy Policy and Terms of Use and to receive email correspondence from us. You may opt out at any time.